Loading organizations...
Loading organizations...
Innovative therapeutic monoclonal antibodies for immune-related disorders.
NovImmune has raised $118.2M across 3 funding rounds.
NovImmune has raised $118.2M in total across 3 funding rounds.
NovImmune has raised $118.2M in total across 3 funding rounds.
NovImmune's investors include Jonathan Hepple, BZ Bank Aktiengesellschaft.
NovImmune has raised $118.2M across 3 funding rounds. Most recently, it raised $30.0M Other Equity in January 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 11, 2016 | $30.0M Other Equity | ||
| Feb 18, 2014 | $67.6M Series B | Jonathan Hepple | |
| Dec 17, 2010 | $20.6M Series B | BZ Bank Aktiengesellschaft |